Cerebras Stock Climbs After Wall Street Buy Calls
Cerebras stock rallied after nine brokerages initiated coverage on June 8, 2026, supporting a near-term rerating as analysts cited wafer-scale chips.
KEY TAKEAWAYS
- Nine brokerages initiated coverage with Buy/Overweight calls after the IPO quiet period.
- Analysts set aggressive 12-month targets clustering $250-$340, e.g., Morgan Stanley $250, Citi $340.
- Initiations frame Cerebras as a wafer-scale AI inference challenger to Nvidia while flagging execution and concentration risks.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
Cerebras Systems Inc. (Nasdaq: CBRS) stock rallied on June 8, 2026, after at least nine brokerages, including Morgan Stanley and Citigroup, initiated coverage with Buy or equivalent ratings and aggressive 12-month price targets. The wafer-scale AI chipmaker is positioned as a potential challenger to Nvidia.
Wall Street Initiations and Targets
Following the expiration of the IPO quiet period, nine brokerages launched coverage on the same day. These included Morgan Stanley, Citigroup, Barclays, UBS, Mizuho, Wedbush, Needham, and Rosenblatt. The research skewed strongly bullish, with firms assigning Buy, Overweight, or Outperform ratings.
The 12-month price targets clustered between $250 and $340. Morgan Stanley set a $250 target with an Overweight rating, Citigroup assigned $340, Mizuho and UBS both set $300 targets with Outperform and Buy ratings respectively, Needham also targeted $300 with a Buy rating, and Wedbush projected roughly $270. Barclays and Rosenblatt fell within the $250–$300 range.
Market activity reflected the wave of coverage, with shares trading more than 17% higher intraday following the reports.
Technology, Customers, and Risks
Cerebras is the only company commercially deploying wafer-scale processors through its Wafer Scale Engine (WSE), a single silicon die roughly the size of a dinner plate. This design concentrates compute on one large chip, reducing inter-chip networking and improving efficiency and latency for targeted AI inference workloads compared with multi-GPU systems.
Analysts emphasize the AI inference market as Cerebras’ primary opportunity, noting a shift in industry spending from training to production-scale inference. High-profile customers include OpenAI and Amazon Web Services, with strategic support from investors such as SoftBank. Analysts estimate visibility toward about $6 billion in annual revenue by 2028 based on existing agreements and cite a $24.6 billion backlog at the end of 2025, heavily tied to OpenAI.
One model projects Cerebras capturing 40–50% of a $130 billion “fast inference” segment, while others reference a broader $292 billion AI inference market.
Risks include customer concentration around OpenAI, the challenge of persuading customers to adopt a non-GPU wafer-scale architecture, entrenched competition from Nvidia in training and inference, and sensitivity to broader market and macroeconomic swings. The stock has declined roughly 35–36% from its post-IPO peak during the pullback.
No recent company-issued forward guidance or SEC filings updating projections appeared in the 72-hour window covered.
Cerebras’ recent IPO raised about $5.5 billion, with shares surging over 100% intraday and closing the debut session up between 68% and 90%, implying a market value near $100 billion. The current wave of buy initiations supports a near-term rerating, contingent on execution and customer diversification.
